EARNINGS MISS CI announced quarterly EPS of $6.64, missing expectations by 15.10%. NYSE - Nasdaq Real Time Price • USD The Cigna Group (CI) Follow Compare 282.98 -20.33 (-6.70%) At close: 4:00:02 PM EST 281.60 -1.38 (-0.49%) After hours: 4:44:47 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Cigna posts Q4 earnings miss, hit by rising medical costs Cigna (CI) shares declined around 8% as the company missed its fourth quarter earnings expectations due to higher medical expenses, though the company is reportedly taking corrective actions. Seana Smith and Josh Schafer discuss Cigna's latest results on Catalysts. Cigna's health benefits segment spent 87.9% of premium revenue on medical expenses in quarter four, according to the health insurer. This issue is not unique to Cigna, as the healthcare industry as a whole faces ongoing cost pressures. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. This post was written by Josh Lynch Cigna (NYSE:CI) Surprises With Q4 Sales Health insurance company Cigna (NYSE:CI) announced better-than-expected revenue in Q4 CY2024, with sales up 28.4% year on year to $65.65 billion. The company expects the full year’s revenue to be around $252 billion, close to analysts’ estimates. Its non-GAAP profit of $6.64 per share was 15.1% below analysts’ consensus estimates. Why Cigna Stock Is Plummeting Today Shares of Cigna (NYSE: CI) were dropping Thursday. While Cigna's Q4 revenue of $65.65 billion beat Wall Street's estimate of $63.44, rising medical costs led to a much more significant earnings-per-share (EPS) miss. The company delivered $6.64 per share, when Wall Street expected $7.82. Cigna Group (CI) Q4 2024 Earnings Call Transcript CI earnings call for the period ending December 31, 2024. Why Cigna (CI) Stock Is Down Today Shares of health insurance company Cigna (NYSE:CI) fell 8.5% in the afternoon session after the company reported underwhelming fourth quarter earnings. EPS in the quarter missed and its full-year EPS guidance missed significantly. This is due to higher-than-expected medical loss ratios. On the other hand, Cigna exceeded analysts’ revenue expectations this quarter. Overall, this was a softer quarter. Cigna Q4 Earnings Miss Estimates on Decline in Medical Membership CI's Q4 results reflect a decline in Individual and Family Plans customers. Management expects 2025 adjusted EPS at a minimum of $29.50, which indicates growth of at least 7.9% from the 2024 figure. Cigna Plunges As Catastrophic Medical Costs Hurt Profit (Bloomberg) -- Cigna Group shares slumped after the health insurer reported cost pressures from surprisingly high catastrophic medical claims that are likely to persist.Most Read from BloombergManhattan’s Morning Commute Time Drops With New Congestion TollTrump's Federal Funding Pause Threatens State Financials Housing Aid Uncertain After Trump’s Spending Freeze MemoTrump Paves the Way to Deputize Local Police on ImmigrationUS Students’ Reading Scores Drop to Worst in More Than 20 YearsCigna’s h Cigna Stock Dives After Earnings. Here’s What Went Wrong. Patients in the U.S. are going to the doctor a lot, and it keeps blindsiding Wall Street investors. It happened again on Thursday morning, when Cigna Group reported quarterly earnings. The results missed estimates and management’s financial guidance for next year was lower than Wall Street expected. Cigna (CI) Reports Q4 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. Cigna (CI) Lags Q4 Earnings Estimates Cigna (CI) delivered earnings and revenue surprises of -15.20% and 3.85%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? Cigna shares tumble as Q4 earnings miss, 2025 outlook disappoints Investing.com -- Shares of The Cigna (NYSE:CI) Group plunged 10.6% in premarket trading on Thursday after the health insurer reported fourth-quarter earnings that fell short of analyst expectations and provided a weaker-than-anticipated outlook for 2025. Cigna: Q4 Earnings Snapshot The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $7.83 per share. The health insurer posted revenue of $65.65 billion in the period. Its adjusted revenue was $65.68 billion, beating Street forecasts. The Cigna Group Reports Fourth Quarter and Full Year 2024 Results, Establishes 2025 Outlook and Increases Dividend Global health company The Cigna Group (NYSE: CI) today reported 2024 results, reflecting continued strength in Evernorth Health Services, while Cigna Healthcare results were impacted by higher stop loss medical costs. Cigna pledges changes to pharmacy, medical benefits following ‘messy’ close to 2024 Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its customers amid widespread discontent with the healthcare system. Cigna Healthcare, Providence to Broaden Southern California Network Cigna Healthcare and Providence are expanding their Los Angeles County network, offering customers several additional care facilities. Evernorth Announces New Cost and Transparency Protections for its Express Scripts Patients Evernorth Health Services, a subsidiary of The Cigna Group (NYSE: CI), today announced several steps it is taking to improve costs and transparency around pharmacy benefits. These changes aim to help patients benefit directly from Express Scripts' negotiations to lower the cost of prescription drugs. They will also enhance transparency about these negotiations for both patients and those who provide their benefits. Investors Met With Slowing Returns on Capital At Cigna Group (NYSE:CI) Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key... Bet on These 5 Top-Ranked Stocks With Rising P/E Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Tyson Foods, Cigna Group, Eldorado Gold, ChampionX and Akamai Technologies. Main Line Health threatens to go out of network with Cigna over contract dispute Main Line Health says Cigna hasn't updated its reimbursement rate since 2016. Cigna says it is negotiating in good faith to find a solution that keeps healthcare affordable for patients. Rising Medical Costs to Affect Cigna Q4 Earnings? Check Estimates Here CI's fourth-quarter results are likely to have benefited from growing premiums and pharmacy revenues. Performance Overview Trailing total returns as of 1/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return CI S&P 500 YTD +2.85% +2.78% 1-Year -3.76% +23.20% 3-Year +27.53% +36.99%